Revenue and Profitability Continued to Improve Year-over-year PLAINVIEW, NY / May 16, 2022 / Vaso Corporation (“Vaso”) (OTC PINK:VASO) today reported its operating results for the three months ended March 31, 2022. “For first quarter of 2022, the Company recorded a total revenue of $17.0 million, up by 3.0% from $16.5 million for the same...
Read More

The Company Reports Significant Growth in Revenue and Profitability PLAINVIEW, NY / March 30, 2022/ Vaso Corporation (“Vaso”) (OTC PINK:VASO) today reported its operating results for the three months and year ended December 31, 2021. “Driven by the extraordinary fourth-quarter growth in our professional sales service segment and equipment segment, the Company’s total revenue for fiscal...
Read More

Revenue for the quarter increased by 6% year-over-year PLAINVIEW, NY / November 15, 2021 / Vaso Corporation (“Vaso”) (OTC PINK:VASO) today reported its operating results for the three months ended September 30, 2021. “Total revenue of the Company grew year-over-year for both the three-month and nine-month periods ending September 30, 2021,” commented Dr. Jun Ma, President...
Read More

PLAINVIEW, NY / ACCESSWIRE / October 29, 2021 / Vaso Corporation (“Vaso”) (OTCMKTS:VASO) today announces the amendment of the sales representation agreement between its subsidiary, Vaso Diagnostics, Inc. d/b/a VasoHealthcare, and GE Healthcare (“GEHC”), the healthcare business unit of General Electric Company (NYSE:GE), originally signed on May 19, 2010. The amendment extends the term of the...
Read More

Company reports net income of $2.8 million with forgiveness of PPP loan PLAINVIEW, NY / August 13, 2021 / Vaso Corporation (“Vaso”) (OTC PINK:VASO) today reported its operating results for the three months ended June 30, 2021. “In the second quarter of 2021, the Company recorded an operating loss of $0.7 million on revenue of $16.1...
Read More